InvestorsHub Logo
Followers 43
Posts 4885
Boards Moderated 0
Alias Born 04/30/2005

Re: Joseph_K post# 428757

Monday, 08/28/2023 6:33:10 PM

Monday, August 28, 2023 6:33:10 PM

Post# of 462040
That's up to the Anavex team to decide whether or not they want to conduct a separate P2 trial for dosage.

IMO, they have enough data with all of the P1s, P2s, and P3 trials (which includes pediatric and adults) to determine dosages for most every age group.

The question is whether those dosages can be applied to other diseases? IMO, yes.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News